Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Gut and Liver ; : 607-614, 2015.
Artículo en Inglés | WPRIM | ID: wpr-216110

RESUMEN

BACKGROUND/AIMS: Proton pump inhibitors (PPIs) act by irreversibly binding to the H+-K+-ATPase of the proton pump in parietal cells and may possibly affect the vacuolar H+-ATPase in osteoclasts. METHODS: We investigated the effect of 8 weeks of PPI treatment on the parameters of bone turnover and compared PPI with revaprazan, which acts by reversibly binding to H+-K+-ATPase in proton pumps. This study was a parallel randomized controlled trial. For 8 weeks, either a PPI or revaprazan was randomly assigned to patients with gastric ulcers. The parameters of bone turnover were measured at the beginning of and after the 8-week treatment period. RESULTS: Twenty-six patients (PPI, n=13; revaprazan, n=13) completed the intention-to-treat analysis. After the 8-week treatment period, serum calcium and urine deoxypyridinoline (DPD) were increased in the PPI group (serum calcium, p=0.046; urine DPD, p=0.046) but not in the revaprazan group. According to multivariate linear regression analysis, age > or =60 years was an independent predictor for the changes in serum calcium and urine DPD. CONCLUSIONS: In elderly patients, administering a PPI for 8 weeks altered bone parameters. Our study suggested that PPIs might directly alter bone metabolism via the vacuolar H+-ATPase in osteoclasts.


Asunto(s)
Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Aminoácidos/efectos de los fármacos , Remodelación Ósea/efectos de los fármacos , Huesos/metabolismo , Calcio/sangre , Análisis de Intención de Tratar , Modelos Lineales , Análisis Multivariante , Osteoclastos/metabolismo , Estudios Prospectivos , Inhibidores de la Bomba de Protones/farmacología , Pirimidinonas/farmacología , Tetrahidroisoquinolinas/farmacología
2.
Korean Journal of Medicine ; : 449-454, 2014.
Artículo en Inglés | WPRIM | ID: wpr-176494

RESUMEN

Spontaneous arterial bleeding has been reported rarely. In a patient consuming heavy amounts of alcohol with alcoholic liver cirrhosis, spontaneous bleeding can be evoked by thrombocytopenia, altered platelet function, and shear stress on fully dilated arteries by portal hypertension. Alcohol consumption itself can also predispose a patient to bleeding by influencing the aggregation and activation of platelets, and altering the coagulation and fibrinolysis pathway. All of these mechanisms could cause patients with alcoholic liver cirrhosis to bleed spontaneously; however, conditions inducing peripheral arterial bleeding are very rare. Here, we report three cases of spontaneous arterial bleeding in patients with liver cirrhosis consuming heavy amounts of alcohol. All of the patients bled without any physical trauma, and the involved arteries were the intercostal arteries in two cases and a gastroduodenal artery in the other case. The patients were treated by angiographic embolization. One expired due to recurrence of arterial bleeding despite repeated angiographic embolization and massive transfusion.


Asunto(s)
Humanos , Consumo de Bebidas Alcohólicas , Arterias , Plaquetas , Embolización Terapéutica , Fibrinólisis , Hemorragia , Hipertensión Portal , Cirrosis Hepática , Cirrosis Hepática Alcohólica , Recurrencia , Trombocitopenia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA